Similar Articles
381 The mononuclear phagocyte system in hepatocellular carcinoma
382 Postoperative outcomes and recurrence patterns of intermediate-stage hepatocellular carcinoma dictated by the sum of tumor size and number
383 Role of immunotherapy in downsizing hepatocellular carcinoma prior to liver transplantation
384 Angiogenesis and immune checkpoint dual blockade: Opportunities and challenges for hepatocellular carcinoma therapy
385 Role of artificial intelligence in the diagnosis and treatment of hepatocellular carcinoma
386 Can DKI-MRI predict recurrence and invasion of peritumoral zone of hepatocellular carcinoma after transcatheter arterial chemoembolization?
387 Immunotherapy for hepatocellular carcinoma: A promising therapeutic option for advanced disease
388 Liver transplantation for hepatocellular carcinoma: Historical evolution of transplantation criteria
389 Delineation of a SMARCA4-specific competing endogenous RNA network and its function in hepatocellular carcinoma
390 Three-in-one incidence of hepatocellular carcinoma, cholangiocellular carcinoma, and neuroendocrine carcinoma: A case report
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA